Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

2.34
+0.17007.83%
Pre-market: 2.30-0.0355-1.52%08:20 EDT
Volume:4.90M
Turnover:11.05M
Market Cap:532.07M
PE:-3.82
High:2.35
Open:2.17
Low:2.15
Close:2.17
52wk High:2.35
52wk Low:0.6617
Shares:227.38M
Float Shares:183.82M
Volume Ratio:2.43
T/O Rate:2.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6118
EPS(LYR):-0.2499
ROE:-783.37%
ROA:-29.63%
PB:-11.54
PE(LYR):-9.36

Loading ...

Press Release: Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

Dow Jones
·
May 13

Gossamer Bio Inc. to Present Preclinical Data on Seralutinib at American Thoracic Society International Conference

Reuters
·
May 08

Gossamer Bio Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 02

3 Promising Penny Stocks With Market Caps Over $100M

Simply Wall St.
·
Apr 26

Gossamer Bio Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Apr 18

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

Insider Monkey
·
Apr 16

BRIEF-Gossamer Bio Announces Inducement Grant Under

Reuters
·
Apr 09

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
Apr 09

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?

Insider Monkey
·
Mar 27

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?

Insider Monkey
·
Mar 27

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 18

Gossamer Bio Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
Mar 14

Piper Sandler Sticks to Their Buy Rating for Gossamer Bio (GOSS)

TIPRANKS
·
Mar 14

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
Mar 14

Gossamer Bio: Q4 Earnings Snapshot

Associated Press Finance
·
Mar 14

Gossamer Bio Q4 2024 GAAP EPS $(0.15) Beats $(0.17) Estimate, Sales $9.379M Beat $6.834M Estimate

Benzinga
·
Mar 14

BRIEF-Gossamer Bio Q4 EPS USD -0.15

Reuters
·
Mar 14

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Business Wire
·
Mar 14

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
Mar 08

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Simply Wall St.
·
Mar 03